2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate
C57H41Cl3F2N26O13 — CID 167636557
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate
2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate (PubChem CID 167636557) has the molecular formula C57H41Cl3F2N26O13 and a molecular weight of 1442.48 g/mol. Its IUPAC name is 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate.
Molecular Properties
| Compound Name | 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate |
|---|---|
| PubChem CID | 167636557 |
| Molecular Formula | C57H41Cl3F2N26O13 |
| Molecular Weight | 1442.48 g/mol |
| Exact Mass | 1440.24 |
| IUPAC Name | 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4-(1-fluoroethenyl)benzoic acid;methyl 2-[(7-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-4,5-dichlorobenzoate;methyl 2-[(8-aminotetrazolo[1,5-b]pyridazine-6-carbonyl)amino]-5-fluoro-4-methoxybenzoate;methyl 4-chloro-5-cyano-2-(3H-imidazo[4,5-c]pyridine-6-carbonylamino)benzoate |
| SMILES | C=C(F)c1ccc(C(=O)O)c(NC(=O)c2cc(N)c3nnnn3n2)c1.COC(=O)c1cc(C#N)c(Cl)cc1NC(=O)c1cc2nc[nH]c2cn1.COC(=O)c1cc(Cl)c(Cl)cc1NC(=O)c1nn2nnnc2cc1N.COC(=O)c1cc(F)c(OC)cc1NC(=O)c1cc(N)c2nnnn2n1 |
| InChI | InChI=1S/C16H10ClN5O3.C14H12FN7O4.C14H10FN7O3.C13H9Cl2N7O3/c1-25-16(24)9-2-8(5-18)10(17)3-11(9)22-15(23)13-4-12-14(6-19-13)21-7-20-12;1-25-11-5-9(6(3-7(11)15)14(24)26-2)17-13(23)10-4-8(16)12-18-20-21-22(12)19-10;1-6(15)7-2-3-8(14(24)25)10(4-7)17-13(23)11-5-9(16)12-18-20-21-22(12)19-11;1-25-13(24)5-2-6(14)7(15)3-9(5)17-12(23)11-8(16)4-10-18-20-21-22(10)19-11/h2-4,6-7H,1H3,(H,20,21)(H,22,23);3-5H,16H2,1-2H3,(H,17,23);2-5H,1,16H2,(H,17,23)(H,24,25);2-4H,16H2,1H3,(H,17,23) |
| InChIKey | OOGAEWYTCGBQJT-UHFFFAOYSA-N |
| XLogP | 5.25 |
| TPSA | 553.16 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 101 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1442.48 |
| LogP ≤ 5 | 5.25 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167636557 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.